Ginkgo Bioworks Holdings, Inc. (DNA) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US37611X2099
Ginkgo Bioworks Holdings, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 170.16 m USD |
| Operating income | -315.28 m USD |
| EBIT | -313.60 m USD |
| Net income | -312.76 m USD |
| Diluted EPS – continuing operations | -5.64 USD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. In addition, the company offers genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection solutions, and plant trait optimization. The company serves pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
More stocks
- ASOS PLC (ASC.L)
- Red Cat Holdings, Inc. (RCAT)
- STRATUS (5356.KL)
- Phoenix Education Partners, Inc. (PXED)
- Wave Life Sciences, Inc. (WVE)
- ACNB CORP (ACNB)
- Yixin Group Ltd (2858.HK)
- Ascopiave SpA (ASC.MI)
- New East New Materials Co Ltd (603110.SS)
- CTT Correios de Portugal SA (CTT.LS)
- Yunnan QuakeSafe Seismic Isolation Technologies Co Ltd Class A (300767.SZ)
- Intuitive Investments Group PLC (IIG.L)
Not investment advice. All data without warranty, price as of 06.11.2026. Details in the risk notice.